High interleukin-6 and impulsivity: determining the role of endophenotypes in attempted suicide

J Isung, S Aeinehband, F Mobarrez, P Nordström, B Runeson, M Asberg, F Piehl, J Jokinen, J Isung, S Aeinehband, F Mobarrez, P Nordström, B Runeson, M Asberg, F Piehl, J Jokinen

Abstract

The dysregulation of inflammation has been associated with depression and, more recently, with suicidal behaviors. The reports regarding the relationship between interleukin-6 (IL-6) and suicide attempts are inconsistent. Personality traits such as impulsivity and aggression are considered endophenotypes and important factors that underlie suicidal behaviors. The aim of the current study was to assess whether plasma and cerebrospinal fluid (CSF) levels of IL-6 are associated with personality traits among suicide attempters. We assessed the relationships among personality traits, IL-6 and violent suicide attempts. The plasma and CSF levels of IL-6 were measured in suicide attempters (plasma=58, CSF=39) using antibody-based immunoassay systems. Personality domains were assessed using the Karolinska Scale of Personality (KSP). IL-6 levels in plasma and CSF were used to predict personality domains via regression models. Plasma IL-6 was significantly and positively correlated with extraversion as well as the KSP subscales impulsivity and monotony avoidance. CSF IL-6 was positively correlated with monotony avoidance. Violent suicide attempts tended to be associated with high plasma IL-6 levels. Plasma and CSF levels of IL-6 were not significantly associated with each other. These results indicate that impulsivity and the choice of a violent suicide attempt method might be related to higher levels of IL-6 in individuals who attempt suicide. The neuroinflammation hypothesis of suicidal behavior on the basis of elevated IL-6 levels might be partly explained by the positive association between IL-6 and impulsivity, which is a key element of the suicidal phenotype.

Figures

Figure 1
Figure 1
Correlation between plasma and cerebrospinal fluid (CSF) interleukin-6 (IL-6) in suicide attempters.
Figure 2
Figure 2
(a) Correlation between plasma interleukin-6 (IL-6) and impulsivity; (b) correlation between plasma IL-6 and monotony avoidance; (c) correlation between cerebrospinal fluid (CSF) IL-6 and monotony avoidance.

References

    1. WHO WHO Suicide prevention (SUPRE)Available at (accessed 26 November 2012).
    1. Runeson B, Asberg M. Family history of suicide among suicide victims. Am J Psychiatry. 2003;160:1525–1526.
    1. Pedersen NL, Fiske A. Genetic influences on suicide and nonfatal suicidal behavior: twin study findings. Eur Psychiatry J Assoc Eur Psychiatr. 2010;25:264–267.
    1. Baud P. Personality traits as intermediary phenotypes in suicidal behavior: genetic issues. Am J Med Genet C Semin Med Genet. 2005;133C:34–42.
    1. Courtet P, Gottesman II, Jollant F, Gould TD. The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies. Transl Psychiatry. 2011;1:e7.
    1. Mann JJ, Arango VA, Avenevoli S, Brent DA, Champagne FA, Clayton P. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry. 2009;65:556–563.
    1. McGirr A, Turecki G. The relationship of impulsive aggressiveness to suicidality and other depression-linked behaviors. Curr Psychiatry Rep. 2007;9:460–466.
    1. Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci. 2005;30:398–408.
    1. Niv S, Tuvblad C, Raine A, Wang P, Baker LA. Heritability and longitudinal stability of impulsivity in adolescence. Behav Genet. 2012;42:378–392.
    1. Coccaro EF, Lee R, Coussons-Read M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry. 2013;71:158–165.
    1. Sutin AR, Terracciano A, Deiana B, Naitza S, Ferrucci L, Uda M, et al. High neuroticism and low conscientiousness are associated with interleukin-6. Psychol Med. 2010;40:1485–1493.
    1. Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L, et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry. 2009;66:287–292.
    1. Janelidze S, Mattei D, Westrin Å, Träskman-Bendz L, Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun. 2011;25:335–339.
    1. Isung J, Aeinehband S, Mobarrez F, Mårtensson B, Nordström P, Asberg M, et al. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl Psychiatry. 2012;2:e196.
    1. Träskman L, Asberg M, Bertilsson L, Sjöstrand L. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry. 1981;38:631–636.
    1. O'Carroll PW, Berman AL, Maris RW, Moscicki EK, Tanney BL, Silverman MM. Beyond the Tower of Babel: a nomenclature for suicidology. Suicide Life Threat Behav. 1996;26:237–252.
    1. Spitzer RL, Williams JB, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R. American Psychiatric Press: Washington, DC, USA; 1990.
    1. Isung J, Mobarrez F, Nordström P, Asberg M, Jokinen J. Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide. World J Biol Psychiatry. 2012;13:468–473.
    1. Schalling D, Edman G. The Karolinska Scales of Personality (KSP). An Inventory for Assessing Temperament Dimensions Associated with Vulnerability for Psychosocial Deviance. The Department of Psychiatry, The Karolinska Institute: Stockholm, Sweden; 1993.
    1. Gustavsson JP, Weinryb RM, Goransson S, Pedersen NL, Asberg M. Stability and predictive ability of personality traits across 9 years. Pers Indiv Differ. 1997;22:783–791.
    1. Hirvikoski T, Jokinen J. Personality traits in attempted and completed suicide. Eur Psychiatry. 2012;27:536–541.
    1. Ortet G, Ibanez MI, Llerena A, Torrubia R. The underlying traits of the Karolinska Scales of Personality (KSP) Eur J Psychol Assess. 2002;18:139–148.
    1. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry J Ment Sci. 1979;134:382–389.
    1. Ortin A, Lake AM, Kleinman M, Gould MS. Sensation seeking as risk factor for suicidal ideation and suicide attempts in adolescence. J Affect Disord. 2012;143:214–222.
    1. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Steinberg JL, Moeller FG. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry. 2005;162:1680–1687.
    1. Turiano NA, Mroczek DK, Moynihan J, Chapman BP. Big 5 personality traits and interleukin-6: evidence for ‘healthy Neuroticism' in a US population sample. Brain Behav Immun. 2013;28:83–89.
    1. Chapman BP, van Wijngaarden E, Seplaki CL, Talbot N, Duberstein P, Moynihan J. Openness and conscientiousness predict 34-week patterns of Interleukin-6 in older persons. Brain Behav Immun. 2011;25:667–673.
    1. Ritchie SA. Connell JMC. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis NMCD. 2007;17:319–326.
    1. Sutin AR, Milaneschi Y, Cannas A, Ferrucci L, Uda M, Schlessinger D, et al. Impulsivity-related traits are associated with higher white blood cell counts. J Behav Med. 2011;35:616–623.
    1. Suchankova P, Holm G, Träskman-Bendz L, Brundin L, Ekman A. The +1444C>T polymorphism in the CRP gene: a study on personality traits and suicidal behaviour. Psychiatr Genet. 2013;23:70–76.
    1. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805–1812.
    1. Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007;21:901–912.
    1. Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8:1254–1266.
    1. Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005;175:3463–3468.
    1. Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci. 2006;61:575–584.
    1. Fisman EZ, Tenenbaum A. The ubiquitous interleukin-6: a time for reappraisal. Cardiovasc Diabetol. 2010;9:62.
    1. Klein DN, Kotov R, Bufferd SJ. Personality and depression: explanatory models and review of the evidence. Annu Rev Clin Psychol. 2011;7:269–295.
    1. Millar K, Lloyd SM, McLean JS, Batty GD, Burns H, Cavanagh J, et al. Personality, socio-economic status and inflammation: cross-sectional, population-based study. PLoS One. 2013;8:e58256.
    1. Mõttus R, Luciano M, Starr JM, Pollard MC, Deary IJ. Personality traits and inflammation in men and women in their early 70s: the Lothian Birth Cohort 1936 study of healthy aging. Psychosom Med. 2013;75:11–19.
    1. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology. 2001;25:892–903.
    1. Jokinen J, Samuelsson M, Nordstrom A-L, Nordstrom P. HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters. J Affect Disord. 2008;111:119–124.
    1. Moberg T, Nordström P, Forslund K, Kristiansson M, Asberg M, Jokinen J. CSF 5-HIAA and exposure to and expression of interpersonal violence in suicide attempters. J Affect Disord. 2011;132:173–178.
    1. Raison CL, Borisov AS, Majer M, Drake DF, Pagnoni G, Woolwine BJ, et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry. 2009;65:296–303.
    1. Song C, Merali Z, Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience. 1999;88:823–836.
    1. Biancotto A, Wank A, Perl S, Cook W, Olnes MJ, Dagur PK, et al. Baseline levels and temporal stability of 27 multiplexed serum cytokine concentrations in healthy subjects. PLoS One. 2013;8:e76091.
    1. Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation. 1995;2:241–248.
    1. De Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol. 2009;10:52.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir